InsiderClue
Insiders · Profile

Bhavnagri Veer

General Counsel at Allogene Therapeutics. Filing since 3 Aug 2020. CIK 0001808980

Company
Date
Role
Action
Shares
Amount
Of holding
ALLO Allogene Therapeutics, Inc.
13 Feb 2023
General Counsel
Sold, plan not stated
3,000
$20.55K
0.5%
ALLO Allogene Therapeutics, Inc.
17 Jan 2023
General Counsel
Sold, plan not stated
3,000
$21.12K
0.5%
ALLO Allogene Therapeutics, Inc.
15 Dec 2022
General Counsel
Sold, plan not stated
5,602
$42.19K
1.0%
ALLO Allogene Therapeutics, Inc.
15 Mar 2022
General Counsel
Sold, plan not stated
8,849
$67.96K
2.1%
ALLO Allogene Therapeutics, Inc.
15 Sep 2021
General Counsel
Sold, plan not stated
5,000
$123.84K
1.2%
ALLO Allogene Therapeutics, Inc.
16 Aug 2021
General Counsel
Sold, plan not stated
5,000
$104.99K
1.2%
ALLO Allogene Therapeutics, Inc.
15 Jul 2021
General Counsel
Sold, plan not stated
5,000
$107.75K
1.2%
ALLO Allogene Therapeutics, Inc.
15 Jun 2021
General Counsel
Sold, plan not stated
5,000
$126.60K
1.2%
ALLO Allogene Therapeutics, Inc.
18 May 2021
General Counsel
Sold, plan not stated
5,000
$150.00K
1.2%
ALLO Allogene Therapeutics, Inc.
17 May 2021
General Counsel
Sold, plan not stated
5,000
$141.48K
1.2%
ALLO Allogene Therapeutics, Inc.
15 Apr 2021
General Counsel
Sold, plan not stated
10,000
$320.52K
2.3%
ALLO Allogene Therapeutics, Inc.
15 Mar 2021
General Counsel
Sold, plan not stated
16,623
$630.80K
4.0%
ALLO Allogene Therapeutics, Inc.
6 Oct 2020
General Counsel
Sold, plan not stated
10,000
$400.00K
2.7%
ALLO Allogene Therapeutics, Inc.
1 Oct 2020
General Counsel
Sold, plan not stated
25,000
$912.91K
6.6%
ALLO Allogene Therapeutics, Inc.
1 Sep 2020
General Counsel
Sold, plan not stated
25,000
$883.97K
6.6%
ALLO Allogene Therapeutics, Inc.
3 Aug 2020
General Counsel
Sold, plan not stated
31,553
$1.16M
8.2%
16 decisions on file.